Shire Plc American Depositary Receipts jumped almost 7% in premarket trade Thursday, after the company reported positive results from a late-stage trial of a treatment for Hereditary Angioedema (HAE), ...
LONDON (Reuters) - Shire Plc (SHP.L) shares gained more than 3 percent on Monday following news U.S. regulators had approved NPS Pharmaceuticals Inc's (NPSP.O) drug Natpara, validating Shire's ...
LONDON (Reuters) - Shares in Shire jumped nearly 4 percent on bid expectations in early trade on Tuesday after Reuters reported that the drugmaker had hired investment bank Citi as a defence adviser.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results